Sign In
Buy SLS
$12.79
-0.600 (-4.48%)
At Close: Jul 15, 2026
SELLAS Life Sciences: Strong Buy-Imminent Catalyst, Dual-Platform Pipeline, And A Market That Hasn't Caught Up
03:06pm, Tuesday, 14'th Jul 2026
SELLAS Life Sciences is at the center of a debate over its event-driven Phase 3 REGAL trial for GPS in AML CR2 patients. The extended REGAL timeline should not be interpreted as evidence of failure or
SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance Wall
11:09am, Wednesday, 08'th Jul 2026
SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares are trading lower Wednesday as investors take profits following the stock's strong longer-term uptrend, with broader risk appetite also softer across
SELLAS Life Sciences Shares Fall Tuesday: What's Driving The Move?
09:39am, Tuesday, 30'th Jun 2026
SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares are trading lower Tuesday as traders digest the recent breakout run and early profit-taking shows up even with momentum still elevated from the compa
Amentum Wins NASA'S COSMOS Contract to Advance Spaceflight Mission Operations
09:00am, Tuesday, 30'th Jun 2026
[url="]Amentum[/url] (NYSE: AMTM), a global leader in advanced engineering and technology solutions, has been awarded NASA's Consolidated Spaceflight Mission O
Sellas Life Sciences: The AML Platform Is More Interesting Than The Binary Event
04:25am, Saturday, 27'th Jun 2026
SELLAS Life Sciences is advancing a dual-path AML franchise with GPS nearing pivotal Phase 3 REGAL readout and SLS009 progressing in high-risk AML settings. SLS has strengthened its cash position to $
What's driving SLS stock higher today and what comes next?
12:30pm, Friday, 26'th Jun 2026
Sellas Life Sciences (SLS) shares are extending gains on Jun. 26 following a key regulatory filing that disclosed a series of comprehensive corporate amendments regarding executive compensation and pr
SELLAS Stock Hits New Highs: What's Happening Today?
10:54am, Friday, 26'th Jun 2026
SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares are pushing higher Friday morning, adding to Thursday's strong rally.
Why SELLAS Life Sciences Stock Is Surging Thursday
02:07pm, Thursday, 25'th Jun 2026
Shares of SELLAS Life Sciences Group Inc. (NASDAQ:SLS) are rallying sharply Thursday, hitting a fresh 52-week high of $11.06, up over 16% in midday trading. The clinical-stage biopharmaceutical compan
SELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move?
09:41am, Wednesday, 20'th May 2026
Sellas Life Sciences Group Inc (NASDAQ:SLS) shares are trading higher on Wednesday as traders react to the company's latest update on its acute myeloid leukemia pipeline and the timeline for a pivotal
SELLAS Life Sciences to Participate in Upcoming Investor Conferences
08:00am, Thursday, 14'th May 2026
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the developmen
SELLAS Life Sciences Nears Pivotal Trial Readout As Leukemia Pipeline Progresses
10:18am, Wednesday, 13'th May 2026
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) reported first-quarter (Q1) 2026 financial results on Tuesday while highlighting progress across its acute myeloid leukemia (AML) pipeline.
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
04:05pm, Tuesday, 12'th May 2026
– Contract Research Organization for the Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) Informed the Company that 78 Events have Occurred in the Trial as of May
Sellas Life Sciences: 'Hold' As Phase 3 AML Study Progresses To Key Event
03:06pm, Thursday, 23'rd Apr 2026
SELLAS Life Sciences is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst. The company's GPS targets WT1 in AML, with prior phase 1/2 data showing a median
Wall Street Analysts Think SELLAS Life Sciences Group, Inc. (SLS) Could Surge 66.09%: Read This Before Placing a Bet
10:56am, Monday, 20'th Apr 2026
The mean of analysts' price targets for SELLAS Life Sciences Group, Inc. (SLS) points to a 66.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong
All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy
01:00pm, Thursday, 26'th Mar 2026
SELLAS Life Sciences Group, Inc. (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near ter
